Objective: Hyperinsulinemic euglycemia, or the Insulin Resistance Syndrome (IRS), is associated with increased morbidity and mortality. Although thought to be associated with proinflammatory states, little work has been done in this area. Here, we determined the impact of IRS on functional, biochemical, metabolic, and inflammatory status in a high risk population: elderly women in nursing homes. Research Design and Methods: Functional, biochemical, metabolic, and inflammatory parameters were measured in 100 consecutive ambulatory, elderly, nursing home females. Diabetics and residents with FBS >110 mg/dl were excluded. Remaining residents were classified as insulin resistant (IR: insulin>100 pM) or non-insulin resistant (NIR). Results: 16 residents had IR and 53 NIR. No differences in functional status, BMI, renal function, C-reactive protein, or immune cell levels were found. FBS was higher in IR (94.1 ± 8
Insulin resistance syndrome (IRS) is characterized by a decreased tissue sensitivity to the action of insulin, leading to a compensatory increase in insulin secretion (1) . It is thought that most adults with IRS maintain normal glucose levels and will never develop overt type 2 diabetes, but are nonetheless at increased risk for cardiovascular disease. Whereas diabetes mellitus is defined on the basis of serum glucose levels regardless of insulin status, IRS is defined on the basis of serum insulin levels regardless of glucose status. The population of IRS that clearly does not overlap with diabetes mellitus is that with euglycemic hyperinsulinemia.
Residents with IRS, despite euglycemia, are at increased risk for hypertension, stroke, polycystic ovary syndrome, and nonalcoholic steatohepatitis (2) .
Because measuring serum insulin is not part of routine clinical practice, diagnosing IRS is difficult.
As such, diagnosis is often made based on the presence of secondary criteria, such as hypertension, history of glucose intolerance, or elevated BMI (2) . As these are also associated with diabetes mellitus and likely are sequella developing from IRS, such a diagnostic approach makes it difficult to ascertain incidence of IRS or to study early pathological events that may be unique to it. These difficulties are magnified in the elderly as many of the secondary criteria are independently associated with aging.
Here, we studied a population of elderly, ambulatory women living in longterm care facilities in a midwestern metropolitan area.
We assessed in the euglycemic subset their functional, biochemical, metabolic, and inflammatory parameters as a function of endogenous serum insulin levels.
Research Design and Methods
Patient Population: Studies were approved by the local IRB and consent forms obtained on all participants. 100 elderly ambulatory females aged 65 years or older were recruited from eight long-term care facilities in the St. Louis metropolitan area. Exclusion criteria for the study were non-ambulatory status or those with a contraindication for exercise. A fasting morning blood sample was drawn and measured for glucose, electrolytes, blood urea nitrogen, creatinine, blood urea nitrogen/anion gap ratio, anion gap, c-reactive protein, pre-albumin, albumin, transferrin, white blood cells (further assessed as percentages of neutrophils, lymphocytes, eosinophils, and segments), platelets, red cell indices, and hemoglobin. Blood samples were also measured blinded with multiplex kits (Millipore, St. Charles, MO) for insulin, C-peptide, leptin, total amylin, adiponectin, resistin, interleukin (IL)-1 alpha, IL-1ß, IL-1 receptor antagonist, IL-2, IL-4, IL-6, IL-8, IL-10, interferon-gamma, tumor necrosis factoralpha (TNF), eotaxin, macrophage inflammatory protein-1 alpha, and RANTES. Any multiplex levels above the detection limit were diluted and assayed again. Any multiplex levels below the detection limit were assigned the value of 1.0. Residents were weighed, their height measured, and their body mass index calculated as weight (in kg) divided by the square of height (in m). Mini-mental status examination (3), mininutritional assessment (4), activities of daily living (5), the geriatric depression scale (6), functional independence measure (7) the comorbidity scale of Charlson (8; 9) , the timed get up and go test (10) , the timed six meter walk (11), the six minute walk (12) , smoking history, and alcohol consumption history were assessed at the time of enrollment.
Residents on any form of medication for the treatment of diabetes mellitus or with a fasting blood sugar of 110 mg/dl or greater were excluded from further analysis. One resident with abnormally high values for Cpeptide (>4500 pM), insulin (2280 pM), and total amylin (>4500 pM) was excluded from the study. The 69 remaining nondiabetic, euglycemic residents were classified as insulin resistant (IR; fasting serum insulin >100 pM, n = 16) or non-insulin resistant (NIR, fasting serum insulin <100 pM, n = 53). Two inflammatory scores were calculated by first determining the median values for a parameter and then calculating the number of subjects who had values higher than the median. The first inflammatory score included the parameters of C-reactive protein, TNF, IL-6, and IL-1ß and values ranged from 0-4. The second inflammatory score excluded C-reactive protein for a measure based entirely on cytokine measures.
Analysis of data:
Means are reported with their standard deviations and n. Results were analyzed using the SPSS v14 package. IR and NIR subjects were compared using Chisquare tests for categorical variables and Mann-Whitney-U tests for continuous variables.
Rank-order correlations (Spearman's r) were used to investigate associations.
Statistical significance was determined at the 0.05 level and statistical trend defined as 0.05<P<0.10.
Results
The mean insulin levels were 280 ± 313 pM (IR group, n = 16) and 58.4 ± 18.51 pM (NIR group, n = 53). Table 1 compares resident characteristics.
There were no differences in age, morphometric measures, or functional, nutritional, or mental status, although there was a statistical trend (P=.09) towards an elevated BMI in the insulin resistant group. Table 2 shows that glucose was slightly elevated in the NIR group (P<0.05), but no differences in the other general chemistries.
Renal function as measured by creatinine or the BUN/creatinine ratio was similar between the two groups.
C-peptide (P<0.05), amylin (P<0.001), and leptin (P<0.01) were all elevated in the IR group (Table 2) . Adiponectin showed a statistical trend (P=0.08) towards being lower in the IR group.
The proinflammatory cytokine TNF was about 50% higher (P<0.01; Table 2 ); although the other cytokines except for MIP-1α and RANTES were arithmetically higher in the IR group, none reached statistical significance. C-reactive protein, immune cell measures, and neither of the proinflammatory indices were significantly different between the IR and NIR groups.
Ratios of leptin/BMI (P<0.01), insulin/c-peptide (P<0.001), insulin/BMI (P<0.001), and insulin/TNF (P<0.001) were significantly higher in the IR group (Table 3) . The ratios for insulin/leptin, TNF/BMI, and insulin/amylin were not different between the two groups.
Significant positive correlations were found between BMI and leptin (P<0.001, r = 0.68), TNF and insulin (P<0.01, r = 0.36), leptin and insulin (P<0.01, r = 0.31), and insulin and the leptin/BMI ratio (P<0.01, r = 0.34). Figure 1 shows the relation between TNF and log insulin (Y = 9.21x + 5.36, r = 0.533, n = 69, p<<0.01). Adiponectin and leptin were inversely correlated (P<0.001, r = -0.50). There were trends for associations between C-reactive protein vs TNF (P=0.07) and insulin vs BMI (P=0.06). TNF and leptin did not correlate.
Discussion
IRS is increasingly recognized as a harbinger of classical disease states, including diabetes mellitus and metabolic syndrome X.
It has been postulated that insulin resistance, diabetes mellitus, and metabolic syndrome X are all associated with a proinflammatory state, but it has been difficult to determine whether the proinflammatory state is a cause or effect of these conditions. Furthermore, it is unclear what proinflammatory cytokines are most likely to be elevated early in the course of these conditions, especially in insulin resistance. All these conditions also become increasingly common with aging. Here, we examined functional, chemical, metabolic, and inflammatory status in a relatively healthy and uniform population of elderly women. We excluded any person taking diabetic medications and used strict criteria for euglycemia (i.e., fasting glucose <110 mg/dl).
These residents had significant impairments in their abilities to care for themselves, requiring nursing home placement.
They were, however, the healthiest members of the nursing home population, having on average mild to moderate cognitive and functional impairments. Mean insulin levels were 280 pM in the IR group and 58.4 pM in the NIR group. It is significant that the majority of recruited residents had neither IRS, fasting hyperglycemia, nor frank diabetes mellitus as it is generally assumed that residents this debilitated would have near universal insulin resistance (13) .
Those with IR did not differ from the NIR group in age, height, weight, smoking history, drinking history, or nutritional risk as measured by the mini-nutritional assessment tool. Importantly, the two groups did not differ in BMI, although the insulin resistant group had a BMI that was about 6% greater (P=0.09). The groups did not differ on measures of severe illness as measured by the comorbidity scale of Charlson, a medical record-based inventory of 19 conditions associated with in-patient mortality. Functional status did not differ between the two groups as measured by four different measures: the functional index measure, the activities of daily living, the six meter walk, and the 6-min walk. This lack of differences suggests that the muscle wasting, sarcopenia, and frailty associated with IR (13) is confounded by aging and other associated factors and more likely a later association with IRS. Levels of depression as measured by the geriatric depression scale or dementia as measured by the mini-mental status examination were similar between the groups. Balance and risk of falls as measured by the timed get up and go test was also similar. These lack of differences show that any deleterious effects of insulin resistance had not yet manifested itself in common indices of health status.
These groups did not differ in the indicators of general inflammation, including CRP, prealbumin, albumin, transferring, or immune cell levels, nor in hemoglobin or hematocrit. They also did not differ in cholesterol levels.
Hyperlipidemia is a hallmark of metabolic syndrome X, whereas low cholesterol (<160) is used in geriatrics as an index of malnutrition. Overall, therefore, insulin resistance had little impact on immediate general health, giving us the opportunity to examine an early stage of IRS.
Although the study included only those with a fasting blood glucose of less than 110 mg/dl, glucose was higher (P<0.05) in the IR (94.2 mg/dl) vs the NIR group (87.9 mg/dl). The IR fasting glucose was well within normal limits and only 7% higher than in the NIR group. Nevertheless, it is a clear indication that even this early stage of IRS is associated with impairments in glucose handling.
In contrast to the lack of differences in routine laboratories, several hormone levels were elevated in the insulin resistant group. As expected, insulin C-peptide was elevated, but only about 15%.
Interestingly, the insulin/C-peptide level was about 5 fold higher in the insulin resistant group, suggesting that insulin or C-peptide clearance or degradation was affected more than secretion. Any difference in insulin clearance cannot be ascribed to renal failure, as serum creatinine did not differ between the IR and NIR groups. Amylin, co-secreted with insulin in a 1:1 molar ratio from the pancreas, was also elevated over 4 fold in the insulin resistant population. The ratio of insulin and amylin did not differ between the two groups, suggesting that the two peptides were cleared and secreted in a similar fashion.
Serum insulin levels were highly correlated with serum leptin levels, consistent with IR being associated with obesity. As expected from numerous other studies, leptin also correlated positively with BMI and inversely with adiponectin.
Leptin was increased about 70% in the IR population (P<0.01). This was unexpected, given that the average BMI for the IR group was only marginally (6%) and not significantly higher than in the NIR group. However, BMI is a cruder measure of adiposity than serum leptin, as BMI does not distinguish between lean and adipose tissue. The leptin/BMI ratio was also about 70% higher in the IR group in comparison to the NIR group (P<0.005). This suggests either that the insulin resistant group was hypersecreting leptin per unit of fat mass or that a greater percent of their body weight was adipose tissue. The latter seems more likely considering the recent description of the sarcopenic obese. These residents, despite having a normal or high BMI, have decreased muscle mass and so a greater proportion of their BMI is adipose tissue. Such residents are at an increased risk for mortality and morbidity. The current findings suggest that IR could be an early component of sacropenic obesity.
The strong associations of leptin and leptin/BMI with serum insulin and their segregation between the NIR and IR groups suggests a strong association between obesity and IR. However, BMI only showed a trend towards association with insulin (p = 0.06), whereas the leptin/BMI ratio correlated better with serum insulin than did leptin alone. This again suggests that serum levels of leptin are much more sensitive at inventorying the metabolic parameters associated with IR than is the BMI. This is further suggested by the finding that the leptin/insulin ratio did not differ between the IR and NIR groups, even though each of these components alone were very different. Thus, leptin and insulin overlap to some degree in their abilities to distinguish the IR and NIR groups, but likely retain independent predictive abilities.
In contrast, serum adiponectin levels correlated even more strongly with leptin than did insulin. Adiponectin is secreted from fat and can reverse insulin resistance and hyperglycemia, possibly through its ability to regulate proinflammatory cytokines (14) (15) (16) (17) . However, adiponectin did not distinguish IR from NIR, being decreased in the IR group by about 25% (P=0.08).
Evidence for a proinflammatory state was most clearly revealed by a significant (P<0.01) elevation in TNF. TNF levels were 50% higher in IR compared to NIR residents. Arithmetic increases which did not reach statistical significance were evident in every other proinflammatory and anti-inflammatory cytokine measured with the exceptions of MIP-1 alpha and RANTES. The lack of statistical significance in the elevations of some of the cytokines may have been in part caused by the large variance within groups. To further assess a global trend of cytokine elevation and to negate variance, we computed two proinflammatory indices, both of which included TNF that assessed elevations on nonparametric scoring. However, neither of these summations was different between the two populations. This suggests that even with the power of including a statistically significant component (TNF), there is no evidence for a statistically meaningful global cytokine increase. This supports TNF as being the primary cytokine whose elevation is relevant in early insulin resistance.
The role of serum TNF is further supported by a strong correlation with serum insulin levels. This correlation between TNF and insulin was even stronger than that between leptin and insulin. One source of serum TNF could be from adipose tissue. However, serum TNF levels did not correlate with serum leptin levels. In some studies, TNF and leptin levels correlate, presumably because both can be secreted from fat. However, TNF has sources in addition to adipose tissue, whereas adipose tissue is essentially the sole source of serum leptin. Therefore, the lack of correlation between leptin and TNF suggests that the source of elevated TNF was not adipose tissue. Further supporting this was the findings that TNF/BMI ratios did not distinguish between IR and NIR groups the way leptin/BMI did and the TNF/insulin ratio, unlike the leptin/insulin ratio, still distinguished the IR and NIR groups. Therefore, TNF and leptin behaved very differently, making it unlikely that adipose tissue was the source of the elevation in TNF. TNF did show a statistical trend with CRP (p = 0.07), suggesting it might have arisen from a generalized proinflammatory condition.
In conclusion, we examined early insulin resistance in a population of elderly women living in a long-term care facility before debility ascribable to IR had arisen. Although no functional impairments were found between the IR and NIR groups, we found other parameters were already changing. Despite exclusion of any person with a serum fasting glucose >110, a slight, statistically significant increase in serum glucose of 7% demonstrated an early glucose intolerance in the IR group. Differences in Cpeptide and the insulin/C-peptide ratio suggested an increased insulin secretion and decreased insulin clearance in the IR group. Increased leptin and leptin/BMI ratios in the absence of differences in BMI suggest that the IR group had a higher percent of body fat mass and that IR could be related to sarcopenia of obesity. TNF was the one proinflammatory cytokine statistically elevated in the IR group. The lack of correlation of TNF with BMI or leptin suggests that the TNF did not originate from fat.
Thus, early IR is associated with elevations of leptin even after correction of BMI and a proinflammatory state as evidenced by elevated levels of serum TNF. 
